Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.

Abstract

Antimony resistant strains of L. donovani were wide spread over different geographical areas in Bihar. SAG cured lesser percentage of VL cases clinically compared to AMB and should be replaced by AMB as a first line drug.